Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics?

Key Takeaways SYK's Q3 revenues are estimated at $6.04B, up nearly 10% year over year, with EPS of $3.14.SYK's Mako robotics and new product launches likely fueled Orthopaedics and Spine segment growth.SYK's MedSurg demand stayed strong, though tariffs and Inari integration costs may have pressured margins.Stryker Corporation (SYK) is scheduled to release third-quarter 2025 results on Oct. 30, after market close. In the last reported quarter, the company delivered an earnings surprise of 2.29%.Q3 EstimatesT ...